ProPhase Labs, Inc. (PRPH) Dividend History

ProPhase Labs, Inc. is a healthcare company primarily involved in the development, manufacturing, and marketing of wellness, diagnostic, and other healthcare products. Founded in 1986, the company has a diverse portfolio that includes dietary supplements, over-the-counter drugs, and diagnostic testing services, with a focus on innovative solutions to improve health and wellness.

711 Stewart Ave, Suite 200, New York, NY, 11530
Phone: (215) 345-0919
Website: https://www.prophaselabs.com

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 03, 2022 $0.30 05/24/2022 05/25/2022
March 10, 2022 $0.30 02/28/2022 03/01/2022
June 03, 2021 $0.30 05/24/2021 05/25/2021
December 12, 2019 $0.25 12/02/2019 12/03/2019
January 24, 2019 $0.25 01/09/2019 01/10/2019
Show more

Dividends Summary

  • ProPhase Labs, Inc. has issued 6 dividend payments over the past 4 years
  • The most recent dividend was paid 1192 days ago, on June 3, 2022
  • The first recorded dividend was paid on June 5, 2018
  • The highest dividend payout was $1.00 per share
  • The average dividend over this 4 year span is $0.40 per share
  • ProPhase Labs, Inc. has decreased its dividend payments by 70.00% since 2018

Company News

  • ProPhase Labs Posts Narrower Q2 Loss

    ProPhase Labs reported a Q2 2025 revenue of $1.2 million, missing analyst expectations, but narrowed its GAAP loss to $(0.11) per share. The company is focusing on cost reduction, potential insurance receivables recovery, and exploring a sale of its Nebula Genomics division.

    The Motley Fool
  • ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

    ProPhase Labs announced the formation of a Clinical Science Advisory Board to support the commercialization of its BE-Smart molecular test for esophageal disease. The advisory board includes experts in the field and aims to accelerate the regulatory and commercialization pathway for the test.

    GlobeNewswire Inc.
  • Rare Stock Picks In May 2024 - From 29 Discerning Analysts

    In our monthly Rare Stock Picks series, we're highlighting May 2024 investment picks. Click here for the list of May 2024 Buy recommendations.

    Seeking Alpha
    Featured Companies: ACN BDN CELH DBX DE EOLS FENY FOXF FTNT HLMN KARO KMI KOMP MSOS NFLX ORCL TROW WBD ZGN
  • Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates

    Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 10.91% and 9.51%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: IONS
  • Analyst Expectations for ProPhase Labs's Future

    Over the past 3 months, 4 analysts have published their opinion on ProPhase Labs (NASDAQ:PRPH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 3 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, ProPhase Labs has an average price target of $14.75 with a high of $15.00 and a low of $14.00. Below is a summary of how these 4 analysts rated ProPhase Labs over the past 3 months. The greater the number of bullish ...Full story available on Benzinga.com

    Benzinga
Page data last updated 09/07/2025 00:02:30 UTC